@article{2d69fb16ff724b4eb0e19fcf271feb7f,
title = "Do we need more genome wide association studies?",
author = "Stephan Menzel",
note = "Funding Information: The authors have no disclosures to make regarding this editorial. With regard to work outside this publication, MCT has received honoraria from MJH Life Sciences, VJHemOnc, and Curio Science. LER has received research funding from the American Society of Hematology and Pfizer; has minority ownership interest in Abbott Laboratories; provides consultancy services for AbbVie, AstraZeneca, Pharmacyclics, the Vaniam group and, uncompensated, for Verastem. ARM has received grants and personal fees from and is a data safety monitoring board member for TG Therapeutics; has received grants and personal fees from Loxo Oncology (a wholly owned subsidiary of Eli Lilly), Genentech, AbbVie, AstraZeneca, Adaptive, Pharmacyclics, and Curio Sciences; has received grants from Sunesis, Regeneron, Pfizer, Aprea, Aptose, and DTRM; has received non-financial support from the NCCN, CLL society, and Lymphoma Research Foundation; and has received grants from and sat on a steering committee for Verastem. Funding Information: SM is presently supported by an MRC project grant to investigate the genetic determination of fetal-hemoglobin levels in sickle cell disease. Copyright: Copyright 2021 Elsevier B.V., All rights reserved.",
year = "2021",
month = sep,
doi = "10.3324/haematol.2021.278642",
language = "English",
volume = "106",
pages = "2302--2303",
journal = "Haematologica",
issn = "0390-6078",
publisher = "Ferrata Storti Foundation",
number = "9",
}